The Spectrum of CHM Gene Mutations in Choroideremia and Their Relationship to Clinical Phenotype

Overview

Journal Invest Ophthalmol Vis Sci

Specialty Ophthalmology

Date 2016 Nov 8

PMID 27820636

Citations 45

Authors

Matthew P Simunovic

Jasleen K Jolly

Kanmin Xue

Thomas L Edwards

Markus Groppe

Susan M Downes

Robert E MacLaren

Affiliations

Soon will be listed here.

Abstract

Purpose: We report the underlying genotype and explore possible genotypic-phenotypic correlations in a large cohort of choroideremia patients.

Methods: We studied prospectively a cohort of 79 patients diagnosed within a tertiary referral service for patients with retinal dystrophies. Phenotypic evaluation consisted of clinical examination, including visual acuity and residual retinal area by fundus autofluorescence (FAF). Genotype was established by sequencing. We also investigated whether particular genotypes were associated with more severe phenotypes by performing analysis of covariance (ANCOVA), with visual acuity and FAF as the dependent variables and age as the covariant.

Results: A total of 74 (94%) of patients in our cohort had causative mutations by sequencing, the majority of which were anticipated to be null. Of these, 35 (47%) had insertions and deletions, 13 (18%) had mutations predicted to affect splicing, and 26 (35%) had single point mutations. In the latter case, 13 of 21 (62%) pedigrees with single point mutations were C to T transitions at C-phosphate-G (CpG) dinucleotides. These mutations were spread across 5 of only 24 CpG dinucleotides in the entire CHM cDNA. Furthermore, these 5 locations are the only sites at which C to T transitions result in a stop codon. No clear evidence was found for genotype-phenotype correlation except in the instance of a patient with a large deletion involving neighbouring sequences.

Conclusions: In patients with a diagnosis of choroideremia made by a specialty service, there is a high likelihood of establishing a genetic diagnosis. The majority of causative mutations appear to be null and, therefore, may benefit from gene replacement therapy. A disproportionate number of single point mutations observed were C to T transitions, consistent with the evolutionary decay of CpG dinucleotides through methylation and subsequent deamination. Hence, the development of choroideremia in such patients may represent the unwanted consequence of human evolution; de novo mutations are predicted to arise at these sites in future generations. (ClinicalTrials.gov number, NCT01461213.).

Citing Articles

Choroideremia: The Endpoint Endgame.

Abdalla Elsayed M, Taylor L, Josan A, Fischer M, MacLaren R Int J Mol Sci. 2023; 24(18).

PMID: 37762657 PMC: 10532430. DOI: 10.3390/ijms241814354.

Diagnostic genome sequencing improves diagnostic yield: a prospective single-centre study in 1000 patients with inherited eye diseases.

Weisschuh N, Mazzola P, Zuleger T, Schaeferhoff K, Kuhlewein L, Kortum F J Med Genet. 2023; 61(2):186-195.

PMID: 37734845 PMC: 10850689. DOI: 10.1136/jmg-2023-109470.

Clinical and imaging findings of choroideremia in a pediatric patient due to a novel frameshift mutation.

Moussa M, Scoles D, Branham K, Fahim A, Capone Jr A Am J Ophthalmol Case Rep. 2022; 28:101718.

PMID: 36247208 PMC: 9562444. DOI: 10.1016/j.ajoc.2022.101718.

Choroideremia Carriers: Dark-Adapted Perimetry and Retinal Structures.

Parmann R, Greenstein V, Tsang S, Sparrow J Invest Ophthalmol Vis Sci. 2022; 63(8):4.

PMID: 35816046 PMC: 9284471. DOI: 10.1167/iovs.63.8.4.

Multimodal imaging reveals retinoschisis masquerading as retinal detachment in patients with choroideremia.

Greig L, Gutierrez K, Oh J, Levi S, Korot E, Tsang S Am J Ophthalmol Case Rep. 2022; 26:101543.

PMID: 35496760 PMC: 9052045. DOI: 10.1016/j.ajoc.2022.101543.

References

Hernando-Herraez I, Garcia-Perez R, Sharp A, Marques-Bonet T . DNA Methylation: Insights into Human Evolution. PLoS Genet. 2015; 11(12):e1005661. PMC: 4684328. DOI: 10.1371/journal.pgen.1005661. View

Ellingford J, Barton S, Bhaskar S, OSullivan J, Williams S, Lamb J . Molecular findings from 537 individuals with inherited retinal disease. J Med Genet. 2016; 53(11):761-767. PMC: 5106339. DOI: 10.1136/jmedgenet-2016-103837. View

van Bokhoven H, Schwartz M, Andreasson S, van den Hurk J, Bogerd L, Jay M . Mutation spectrum in the CHM gene of Danish and Swedish choroideremia patients. Hum Mol Genet. 1994; 3(7):1047-51. DOI: 10.1093/hmg/3.7.1047. View

van den Hurk J, Schwartz M, van Bokhoven H, van de Pol T, Bogerd L, Pinckers A . Molecular basis of choroideremia (CHM): mutations involving the Rab escort protein-1 (REP-1) gene. Hum Mutat. 1997; 9(2):110-7. DOI: 10.1002/(SICI)1098-1004(1997)9:2<110::AID-HUMU2>3.0.CO;2-D. View

Alory C, Balch W . Organization of the Rab-GDI/CHM superfamily: the functional basis for choroideremia disease. Traffic. 2001; 2(8):532-43. DOI: 10.1034/j.1600-0854.2001.20803.x. View

Iossa S, Costa V, Corvino V, Auletta G, Barruffo L, Cappellani S . Phenotypic and genetic characterization of a family carrying two Xq21.1-21.3 interstitial deletions associated with syndromic hearing loss. Mol Cytogenet. 2015; 8:18. PMC: 4376344. DOI: 10.1186/s13039-015-0120-0. View

Rak A, Pylypenko O, Niculae A, Pyatkov K, Goody R, Alexandrov K . Structure of the Rab7:REP-1 complex: insights into the mechanism of Rab prenylation and choroideremia disease. Cell. 2004; 117(6):749-60. DOI: 10.1016/j.cell.2004.05.017. View

Tarpey P, Smith R, Pleasance E, Whibley A, Edkins S, Hardy C . A systematic, large-scale resequencing screen of X-chromosome coding exons in mental retardation. Nat Genet. 2009; 41(5):535-43. PMC: 2872007. DOI: 10.1038/ng.367. View

Holladay J . Proper method for calculating average visual acuity. J Refract Surg. 1997; 13(4):388-91. DOI: 10.3928/1081-597X-19970701-16. View

10.

Ramsden S, OGrady A, Fletcher T, OSullivan J, Hart-Holden N, Barton S . A clinical molecular genetic service for United Kingdom families with choroideraemia. Eur J Med Genet. 2013; 56(8):432-8. DOI: 10.1016/j.ejmg.2013.06.003. View

11.

Francis P, Fishman G, Trzupek K, MacDonald I, Stone E, Weleber R . Stop mutations in exon 6 of the choroideremia gene, CHM, associated with preservation of the electroretinogram. Arch Ophthalmol. 2005; 123(8):1146-9. DOI: 10.1001/archopht.123.8.1146. View

12.

MacLaren R, Groppe M, Barnard A, Cottriall C, Tolmachova T, Seymour L . Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial. Lancet. 2014; 383(9923):1129-37. PMC: 4171740. DOI: 10.1016/S0140-6736(13)62117-0. View

13.

Ayazi S . Choroideremia, obesity, and congenital deafness. Am J Ophthalmol. 1981; 92(1):63-9. DOI: 10.1016/s0002-9394(14)75909-4. View

14.

McTaggart K, Tran M, Mah D, Lai S, Nesslinger N, MacDonald I . Mutational analysis of patients with the diagnosis of choroideremia. Hum Mutat. 2002; 20(3):189-96. DOI: 10.1002/humu.10114. View

15.

Esposito G, De Falco F, Tinto N, Testa F, Vitagliano L, Tandurella I . Comprehensive mutation analysis (20 families) of the choroideremia gene reveals a missense variant that prevents the binding of REP1 with Rab geranylgeranyl transferase. Hum Mutat. 2011; 32(12):1460-9. DOI: 10.1002/humu.21591. View

16.

Poloschek C, Kloeckener-Gruissem B, Hansen L, Bach M, Berger W . Syndromic choroideremia: sublocalization of phenotypes associated with Martin-Probst deafness mental retardation syndrome. Invest Ophthalmol Vis Sci. 2008; 49(9):4096-104. DOI: 10.1167/iovs.08-2044. View

17.

Hernando-Herraez I, Heyn H, Fernandez-Callejo M, Vidal E, Fernandez-Bellon H, Prado-Martinez J . The interplay between DNA methylation and sequence divergence in recent human evolution. Nucleic Acids Res. 2015; 43(17):8204-14. PMC: 4787803. DOI: 10.1093/nar/gkv693. View

18.

Nagy E, Maquat L . A rule for termination-codon position within intron-containing genes: when nonsense affects RNA abundance. Trends Biochem Sci. 1998; 23(6):198-9. DOI: 10.1016/s0968-0004(98)01208-0. View

19.

Bailey I, Lovie J . New design principles for visual acuity letter charts. Am J Optom Physiol Opt. 1976; 53(11):740-5. DOI: 10.1097/00006324-197611000-00006. View

20.

Garcia-Hoyos M, Lorda-Sanchez I, Gomez-Garre P, Villaverde C, Cantalapiedra D, Bustamante A . New type of mutations in three spanish families with choroideremia. Invest Ophthalmol Vis Sci. 2008; 49(4):1315-21. DOI: 10.1167/iovs.07-1169. View